The House Energy & Commerce Subcommittee on Oversight and Investigations convened a hearing on oversight of the 340B Drug Pricing Program. Members of the subcommittee and witnesses agreed that the 340B program is integral to expanding access to care for disadvantaged communities, but given the significant growth of the program in recent years, members expressed support for additional program transparency… (Slifer, June 4, 2024) #340B, #Community Health Centers, #Drug Pricing, #Rural Health